HNRNPH1 and chronic myelogenous leukemia, BCR-ABL1 positive: Liu et al. demonstrated that the short hairpin RNA (shRNA)-mediated knockdown of hnRNPH1 significantly inhibited the proliferation of CML cells and enhanced their sensitivity to imatinib [16].